Riken Omics Science Center (OSC) has purchased CLC bio's enterprise platform software, which it will use for a range of high-throughput sequence-analysis projects.
The high-throughput infrastructure will provide OSC's scientists and Genome Network Analysis Service (GeNAS) with a fast workflow to efficiently manage and analyse large quantities of genomics data.
